1. Home
  2. FPAY vs ALXO Comparison

FPAY vs ALXO Comparison

Compare FPAY & ALXO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FPAY
  • ALXO
  • Stock Information
  • Founded
  • FPAY 2003
  • ALXO 2015
  • Country
  • FPAY United States
  • ALXO United States
  • Employees
  • FPAY N/A
  • ALXO N/A
  • Industry
  • FPAY Diversified Commercial Services
  • ALXO Biotechnology: Pharmaceutical Preparations
  • Sector
  • FPAY Consumer Discretionary
  • ALXO Health Care
  • Exchange
  • FPAY Nasdaq
  • ALXO Nasdaq
  • Market Cap
  • FPAY 31.0M
  • ALXO 28.3M
  • IPO Year
  • FPAY N/A
  • ALXO 2020
  • Fundamental
  • Price
  • FPAY $1.36
  • ALXO $0.46
  • Analyst Decision
  • FPAY Strong Buy
  • ALXO Strong Buy
  • Analyst Count
  • FPAY 2
  • ALXO 6
  • Target Price
  • FPAY $3.25
  • ALXO $3.54
  • AVG Volume (30 Days)
  • FPAY 46.0K
  • ALXO 512.2K
  • Earning Date
  • FPAY 05-20-2025
  • ALXO 05-08-2025
  • Dividend Yield
  • FPAY N/A
  • ALXO N/A
  • EPS Growth
  • FPAY N/A
  • ALXO N/A
  • EPS
  • FPAY N/A
  • ALXO N/A
  • Revenue
  • FPAY $139,800,732.00
  • ALXO N/A
  • Revenue This Year
  • FPAY $12.05
  • ALXO N/A
  • Revenue Next Year
  • FPAY N/A
  • ALXO N/A
  • P/E Ratio
  • FPAY N/A
  • ALXO N/A
  • Revenue Growth
  • FPAY 19.51
  • ALXO N/A
  • 52 Week Low
  • FPAY $0.97
  • ALXO $0.44
  • 52 Week High
  • FPAY $2.37
  • ALXO $17.50
  • Technical
  • Relative Strength Index (RSI)
  • FPAY 54.81
  • ALXO 38.73
  • Support Level
  • FPAY $1.31
  • ALXO $0.41
  • Resistance Level
  • FPAY $1.43
  • ALXO $0.55
  • Average True Range (ATR)
  • FPAY 0.09
  • ALXO 0.05
  • MACD
  • FPAY 0.01
  • ALXO 0.00
  • Stochastic Oscillator
  • FPAY 50.00
  • ALXO 22.76

About FPAY FlexShopper Inc.

FlexShopper Inc is a financial technology company engaged in providing certain types of durable goods to consumers on a lease-to-own basis and providing lease-to-own (LTO) terms to consumers of third-party retailers and e-tailers. Its products include electronics, computers, furniture, mattresses, cameras and camcorders, audio, musical instruments, health, fitness and sports, video games, homes, gardens and tools, appliances, and vacuums on a payment, lease basis. The firm generates a majority of its revenue by leasing its products. The company enables consumers utilizing its e-commerce marketplace to shop for brand-name electronics, home furnishings, and other durable goods on a lease-to-own (LTO) basis.

About ALXO ALX Oncology Holdings Inc.

ALX Oncology Holdings Inc is a clinical-stage immuno-oncology company focused on helping patients fight cancer by developing a pipeline of product candidates based on expertise in protein engineering and oncology led by the CD47 blocker, evorpacept, currently in phase 1 and 2 clinical trials. Cancer cells leverage CD47, a cell surface protein, as a don't eat me signal to evade detection by the immune system. The company is developing a next-generation checkpoint inhibitor designed to have a high affinity for CD47 and to avoid the limitations caused by hematologic toxicities inherent in other CD47 blocking approaches.

Share on Social Networks: